日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer

FOLFIRI3-aflibercept 用于既往接受过治疗的转移性结直肠癌患者

Carola, Candice; Ghiringhelli, François; Kim, Stefano; André, Thierry; Barlet, Juliette; Bengrine-Lefevre, Leïla; Marijon, Hélène; Garcia-Larnicol, Marie-Line; Borg, Christophe; Dainese, Linda; Steuer, Nils; Richa, Hubert; Benetkiewicz, Magdalena; Larsen, Annette K; de Gramont, Aimery; Chibaudel, Benoist

Development and validation of the FRAGIRE tool for assessment an older person's risk for frailty

开发和验证用于评估老年人虚弱风险的 FRAGIRE 工具

Vernerey, Dewi; Anota, Amelie; Vandel, Pierre; Paget-Bailly, Sophie; Dion, Michele; Bailly, Vanessa; Bonin, Marie; Pozet, Astrid; Foubert, Audrey; Benetkiewicz, Magdalena; Manckoundia, Patrick; Bonnetain, Franck

Erratum to: Development and validation of the FRAGIRE tool for assessment an older person's risk for frailty

勘误:FRAGIRE工具的开发和验证,用于评估老年人的虚弱风险

Vernerey, Dewi; Anota, Amelie; Vandel, Pierre; Paget-Bailly, Sophie; Dion, Michele; Bailly, Vanessa; Bonin, Marie; Pozet, Astrid; Foubert, Audrey; Benetkiewicz, Magdalena; Manckoundia, Patrick; Bonnetain, Franck

Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review

不可切除转移性结直肠癌的治疗策略:最新综述

Chibaudel, Benoist; Tournigand, Christophe; Bonnetain, Franck; Richa, Hubert; Benetkiewicz, Magdalena; André, Thierry; de Gramont, Aimery

Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression

匹配的原发性乳腺癌和转移性乳腺癌之间频繁存在的基因差异为识别疾病进展的生物标志物提供了一种方法。

Popławski, Andrzej B; Jankowski, Michał; Erickson, Stephen W; Díaz de Ståhl, Teresita; Partridge, E Christopher; Crasto, Chiquito; Guo, Jingyu; Gibson, John; Menzel, Uwe; Bruder, Carl Eg; Kaczmarczyk, Aneta; Benetkiewicz, Magdalena; Andersson, Robin; Sandgren, Johanna; Zegarska, Barbara; Bała, Dariusz; Srutek, Ewa; Allison, David B; Piotrowski, Arkadiusz; Zegarski, Wojciech; Dumanski, Jan P